Cargando…

Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions

Background Psoas muscle area (PMA) and density (PMD) measured using computed tomography are potential surrogates for evaluating sarcopenia-related mortality risk among patients undergoing cardiovascular interventions. However, the optimal measurement method remains unclear. Methods A retrospective r...

Descripción completa

Detalles Bibliográficos
Autores principales: Järvinen, Otto, Tynkkynen, Juho T., Virtanen, Marko, Maaranen, Pasi, Lindström, Iisa, Vakhitov, Damir, Laurikka, Jari, Oksala, Niku K., Hernesniemi, Jussi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519254/
https://www.ncbi.nlm.nih.gov/pubmed/37738519
http://dx.doi.org/10.1080/07853890.2023.2259798
_version_ 1785109665568260096
author Järvinen, Otto
Tynkkynen, Juho T.
Virtanen, Marko
Maaranen, Pasi
Lindström, Iisa
Vakhitov, Damir
Laurikka, Jari
Oksala, Niku K.
Hernesniemi, Jussi A.
author_facet Järvinen, Otto
Tynkkynen, Juho T.
Virtanen, Marko
Maaranen, Pasi
Lindström, Iisa
Vakhitov, Damir
Laurikka, Jari
Oksala, Niku K.
Hernesniemi, Jussi A.
author_sort Järvinen, Otto
collection PubMed
description Background Psoas muscle area (PMA) and density (PMD) measured using computed tomography are potential surrogates for evaluating sarcopenia-related mortality risk among patients undergoing cardiovascular interventions. However, the optimal measurement method remains unclear. Methods A retrospective registry study of three observational cohorts comprising 2248 patients undergoing cardiovascular interventions (n = 828 for abdominal aortic aneurysms, n = 983 transcatheter aortic valve implantations, and 437 patients undergoing open surgery for thoracic aortic and aortic valve pathology) was conducted. Age-independent associations between mortality and PMA, PMD, PMA indexed to height or body surface area, and the combination of PMA and PMD (lean PMA) were meta-analyzed (using individual participant data) across cohorts after sex stratification with median follow-up times ranging from three to five years for each cohort. RESULTS: In the meta-analysis, psoas muscle measurements were significantly associated with mortality among men (p < 0.05), with high heterogeneity in the associations across all cohorts. There was very little difference in the association between PMA and PMD and mortality (HR 0.83, 95% CI 0.69–0.99, p = 0.002; HR 0.85, 95% CI 0.77–0.94, p = 0.041 for one SD increase in PMA and PMD in the random effects model). Combining PMA and PMD into one composite variable by multiplying their values together showed the most robust association in terms of the magnitude of the effect size in men (HR, 0.77; 95% CI 0.73–0.87, p < 0.001). Indexing PMA to body size did not result in any significant differences in this association. Among women, psoas muscle measurements were not associated with long-term mortality in this meta-analysis. CONCLUSIONS: Different psoas muscle measurements were significantly and very similarly associated with mortality among men but not among women. No single measurement stands out, although combining PMA and PMD seems to be a slightly stronger estimate in terms of effect size and should be considered in further studies.
format Online
Article
Text
id pubmed-10519254
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-105192542023-09-26 Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions Järvinen, Otto Tynkkynen, Juho T. Virtanen, Marko Maaranen, Pasi Lindström, Iisa Vakhitov, Damir Laurikka, Jari Oksala, Niku K. Hernesniemi, Jussi A. Ann Med Cardiology & Cardiovascular Disorders Background Psoas muscle area (PMA) and density (PMD) measured using computed tomography are potential surrogates for evaluating sarcopenia-related mortality risk among patients undergoing cardiovascular interventions. However, the optimal measurement method remains unclear. Methods A retrospective registry study of three observational cohorts comprising 2248 patients undergoing cardiovascular interventions (n = 828 for abdominal aortic aneurysms, n = 983 transcatheter aortic valve implantations, and 437 patients undergoing open surgery for thoracic aortic and aortic valve pathology) was conducted. Age-independent associations between mortality and PMA, PMD, PMA indexed to height or body surface area, and the combination of PMA and PMD (lean PMA) were meta-analyzed (using individual participant data) across cohorts after sex stratification with median follow-up times ranging from three to five years for each cohort. RESULTS: In the meta-analysis, psoas muscle measurements were significantly associated with mortality among men (p < 0.05), with high heterogeneity in the associations across all cohorts. There was very little difference in the association between PMA and PMD and mortality (HR 0.83, 95% CI 0.69–0.99, p = 0.002; HR 0.85, 95% CI 0.77–0.94, p = 0.041 for one SD increase in PMA and PMD in the random effects model). Combining PMA and PMD into one composite variable by multiplying their values together showed the most robust association in terms of the magnitude of the effect size in men (HR, 0.77; 95% CI 0.73–0.87, p < 0.001). Indexing PMA to body size did not result in any significant differences in this association. Among women, psoas muscle measurements were not associated with long-term mortality in this meta-analysis. CONCLUSIONS: Different psoas muscle measurements were significantly and very similarly associated with mortality among men but not among women. No single measurement stands out, although combining PMA and PMD seems to be a slightly stronger estimate in terms of effect size and should be considered in further studies. Taylor & Francis 2023-09-22 /pmc/articles/PMC10519254/ /pubmed/37738519 http://dx.doi.org/10.1080/07853890.2023.2259798 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Cardiology & Cardiovascular Disorders
Järvinen, Otto
Tynkkynen, Juho T.
Virtanen, Marko
Maaranen, Pasi
Lindström, Iisa
Vakhitov, Damir
Laurikka, Jari
Oksala, Niku K.
Hernesniemi, Jussi A.
Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
title Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
title_full Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
title_fullStr Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
title_full_unstemmed Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
title_short Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
title_sort psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
topic Cardiology & Cardiovascular Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519254/
https://www.ncbi.nlm.nih.gov/pubmed/37738519
http://dx.doi.org/10.1080/07853890.2023.2259798
work_keys_str_mv AT jarvinenotto psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT tynkkynenjuhot psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT virtanenmarko psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT maaranenpasi psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT lindstromiisa psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT vakhitovdamir psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT laurikkajari psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT oksalanikuk psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions
AT hernesniemijussia psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions